C57BL/6 Mouse Skeletal Muscle Microvascular Endothelial Cells

Cat.No.: CSC-C8336W

Species: Mouse

Source: Skeletal Muscle

Cell Type: Endothelial Cell; Microvascular Cell

  • Specification
  • Background
  • Scientific Data
  • Q & A
  • Customer Review
Cat.No.
CSC-C8336W
Description
C57BL/6 Mouse Skeletal Muscle Microvascular Endothelial Cells from Creative Bioarray are isolated from skeletal muscle tissue of pathogen-free laboratory mice. C57BL/6 Mouse Skeletal Muscle Microvascular Endothelial Cells are grown in T25 tissue culture flasks pre-coated with gelatin-based coating solution for 2 min and incubated in Creative Bioarray’ Culture Complete Growth Medium generally for 3-7 days. Cultures are then expanded. Prior to shipping, cells are detached from flasks and immediately cryo-preserved in vials. Each vial contains at least 1x10^6 cells per ml and are delivered frozen. The method we use to isolate endothelial cells was developed based on a combination of established and our proprietary methods. These cells are pre-coated with PECAM-1 antibody, following the application of magnetic pre-coated with secondary antibody.
Species
Mouse
Source
Skeletal Muscle
Cell Type
Endothelial Cell; Microvascular Cell
Disease
Normal
Quality Control
C57BL/6 Mouse Skeletal Muscle Microvascular Endothelial Cells are tested for expression of markers using antibody, VE-cadherin (CD144, VE-cadherin Antibody, C-19, sc6458, Santa Cruz); AF1002 (R&D System) or CD31/PECAM-1 (Purified Rat Anti-Mouse CD31, Catalog No. 553370, BD) by immunofluorescence staining or FACS. C57BL/6 Mouse Skeletal Muscle Microvascular Endothelial Cells are negative for bacteria, yeast, fungi and mycoplasma. Cells can be expanded for 3-6 passages at a split ratio of 1:2 under the cell culture conditions specified by Creative Bioarray. Repeated freezing and thawing of cells is not recommended.
Storage and Shipping
Creative Bioarray ships frozen cells on dry ice. On receipt, immediately transfer frozen cells to liquid nitrogen (-180 °C) until ready for experimental use. Live cell shipment is also available on request. Never can primary cells be kept at -20 °C.
Citation Guidance
If you use this products in your scientific publication, it should be cited in the publication as: Creative Bioarray cat no. If your paper has been published, please click here to submit the PubMed ID of your paper to get a coupon.

C57BL/6 mouse primary skeletal muscle microvascular endothelial cells (MMECs) exhibit the characteristic cobblestone morphology of endothelial monolayers and express canonical endothelial markers including CD31/PECAM-1, VE-cadherin (CD144), and von Willebrand factor (vWF), while remaining negative for hematopoietic marker CD45.

A defining advantage of C57BL/6 MMECs is their retention of in vivo-like functional properties-a feature often lost in immortalized lines. These cells can be expanded for 3-6 passages without phenotypic drift, maintaining their capacity to uptake acetylated low-density lipoprotein (ac-LDL), produce nitric oxide (NO), and form capillary-like vascular tubes in vitro. When transplanted subcutaneously or intramuscularly, they form functional microvessels that integrate with the host vasculature, underscoring their therapeutic angiogenic potential.

C57BL/6 MMECs serve as an indispensable platform for studying endothelial dysfunction in metabolic and vascular diseases, angiogenesis, transendothelial resistance (TER), cell adhesion, and migration. Amenable to genetic modification and available in GFP-expressing or Cas9-expressing derivatives, these cells remain a gold-standard ex vivo model bridging basic microvascular biology and translational therapeutic development.

miRNA-6236 Regulation of Postischemic Skeletal Muscle Angiogenesis

In the present study, Mani, Arul M., et al. (2024) used an unbiased approach by performing miRNA sequencing of RNA isolated from ischemic and nonischemic hind limbs from mice following hind-limb ischemia (HLI). They identified a novel miRNA, miRNA-6236 (miR-6236), whose expression was significantly elevated in the ischemic limbs when compared with nonischemic limbs. Little is known about the role of miR-6236 in general, and its role in postischemic angiogenesis has not been studied. Angiogenesis is a critical component of postischemic recovery following HLI, and endothelial cells play a key role. They therefore investigated the role of miR-6236 in ischemic mouse endothelial cells.

In primary mouse and human endothelial cells, they studied the effect of simulated ischemia on miR-6236 expression and assessed its role in cell viability, apoptosis, migration, and tube formation during ischemia. In vitro simulated ischemia-enhanced miR-6236 expression in mouse and human endothelial cells, whereas its inhibition improved viability, migration, tube formation, and reduced apoptosis. Their results show for the first time that miR-6236 plays a key role in regulating postischemic perfusion recovery and angiogenesis.

Inhibition of miR-6236 by Antagomir Improves Viability and Reduces Apoptosis in Ischemic Mouse Skeletal Muscle Microvascular Endothelial Cells (mSkMVECs).

Fig. 1. miR-6236 inhibition improves viability, reduces apoptosis, and improves migration in ischemic mouse skeletal muscle microvascular endothelial cells (mSkMVECs) (Mani, Arul M., et al., 2024).

Ask a Question

Write your own review

For research use only. Not for any other purpose.

Hot Products